Loading…
Attending this event?
Tuesday, June 18 • 10:00am - 11:00am
#226: Effective Patient Engagement in Patient Experience Data: Practical Insights from Case Studies in Hard-to-Reach Populations

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Tweet Share
Component Type: Forum
Level: Intermediate
CE: ACPE 1.00 Application UAN: 0286-0000-24-577-L04-P; CME 1.00; RN 1.00

This forum will describe strategies for patient engagement to help design patient experience studies (PED). Case studies will illustrate the critical impact of patient engagement on the design of PED studies.

Learning Objectives

Examine the critical role that patient engagement can have on the success of patient experience studies; Implement strategies to overcome challenges associated with patient engagement in hard-to-reach populations.

Chair

Ellen Janssen, PhD

Speaker

Lessons Learned from Publicly Funded Patient Engagement Activities
Caroline Vass, PhD

Industry-Led Case Study
Bennett Levitan, MD, PhD

Industry Update
Brett Hauber, PhD, MA

FDA Update
Robyn Bent, MS, RN

Patient Advocacy Perspective
Bellinda King-Kallimanis, PhD


Speakers
avatar for Ellen Janssen

Ellen Janssen

Director, Global Epidemiology, Benefit-Risk Assessment, Janssen Research & Development LLC, United States
Ellen Janssen in a Director of Benefit-Risk Assessment/Epidemiology at Johnson and Johnson. In her work she lead structured benefit-risk assessments throughout the product lifecycle and conducts patient preferences studies to inform patient-focused decision making. Ellen is passionate... Read More →
avatar for Robyn Bent

Robyn Bent

Director, Patient Focused Drug Development, OCD, CDER, FDA, United States
Robyn Bent is the director of CDER’s Patient-Focused Drug Development (PFDD) Program, an effort to systematically obtain patient input and facilitate the incorporation of meaningful patient input into drug development and regulatory decision making. Prior to joining FDA, Robyn held... Read More →
BH

Brett Hauber

Senior Director, Patient Preference Elicitation, Pfizer Inc, United States
BK

Bellinda King-Kallimanis

Senior Director of Patient-Focused Research, LUNGevity, United States
Bellinda King-Kallimanis is a psychometrician working at the US FDA in the Office of Oncology and Hematology Products in the Office of New Drugs in the Center for Drug Evaluation and Research (CDER). Her work focuses on the use of clinical outcome assessments (COAs) to support patient... Read More →
avatar for Bennett Levitan

Bennett Levitan

Senior Director, Benefit-Risk Assessment, Global Epidemiology, Janssen Research & Development LLC, United States
Bennett Levitan, MD-PhD is Senior Director, Global R&D Epidemiology at Janssen R&D. He introduced state of the art patient-focused benefit-risk (B-R) assessment to Janssen and his team has led numerous clinical teams in B-R assessments and patient preference studies. He co-led development... Read More →
avatar for Caroline Vass

Caroline Vass

Senior Economist, Health Preference Assessment, RTI Health Solutions, United Kingdom
Caroline Vass, PhD, is a Senior Economist at RTI Health Solutions. Her research focuses on using stated preference methods, particularly discrete choice experiments, to elicit preferences for healthcare. She has expertise in both the qualitative and quantitative components of stated... Read More →

Tuesday June 18, 2024 10:00am - 11:00am PDT
Room 15AB San Diego Convention Center 111 W Harbor Drive, San Diego, CA 92101 USA
  05: Patient-Focused Drug Dev, Forum